MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells

References

• Harrison DJ , Geller DS , Gill JD , Lewis VO , Gorlick R . Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer . 2017;18(1):39–50. doi:10.1080/14737140.2018.1413939
   PubMed Web of Science ®Google Scholar
• Grinberg SZ , Posta A , Weber KL , Wilson RJ . Limb salvage and reconstruction options in osteosarcoma. Adv Exp Med Biol . 2020;1257:13–29. doi:10.1007/978-3-030-43032-0_2 32483727
   PubMed Web of Science ®Google Scholar
• Simpson E , Brown HL . Understanding osteosarcomas. JAAPA . 2018;31(8):15–19. doi:10.1097/01.JAA.0000541477.24116.8d
   PubMedGoogle Scholar
• Wang J-Y , Yang Y , Ma Y , et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother . 2020;121:109627. doi:10.1016/j.biopha.2019.109627 31810120
   PubMed Web of Science ®Google Scholar
• Harries LW . Long non-coding RNAs and human disease. Biochem Soc Trans . 2012;40(4):902–906. doi:10.1042/BST20120020 22817756
   PubMed Web of Science ®Google Scholar
• Kopp F . Molecular functions and biological roles of long non-coding RNAs in human physiology and disease. J Gene Med . 2019;21(8):e3104. doi:10.1002/jgm.3104 31177599
   PubMed Web of Science ®Google Scholar
• Zhang X , Hamblin MH , Yin KJ . The long noncoding RNA Malat1: its physiological and pathophysiological functions. RNA Biol . 2017;14(12):1705–1714. doi:10.1080/15476286.2017.1358347 28837398
   PubMed Web of Science ®Google Scholar
• Liu M , Yang P , Mao G , et al. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: a systematic review and meta-analysis. Int J Surg . 2019;72:206–213. doi:10.1016/j.ijsu.2019.11.004 31734255
   PubMed Web of Science ®Google Scholar
• Sun Z , Zhang T , Chen B . Long non-coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) promotes proliferation and metastasis of osteosarcoma cells by targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b. Med Sci Monit . 2019;25:1410–1422. doi:10.12659/MSM.912703 30793707
   PubMed Web of Science ®Google Scholar
• Duan G , Zhang C , Xu C , Xu C , Zhang L , Zhang Y . Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR34a/cyclin D1 axis. Int J Oncol . 2019;54(1):17–28. doi:10.3892/ijo.2018.4600 30365098
   PubMed Web of Science ®Google Scholar
• Cai X , Liu Y , Yang W , et al. Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma. J Orthop Res . 2016;34(6):932–941. doi:10.1002/jor.23105 26575981
   PubMed Web of Science ®Google Scholar
• Fang D , Yang H , Lin J , et al. 17beta-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner. Biochem Biophys Res Commun . 2015;457(4):500–506. doi:10.1016/j.bbrc.2014.12.114 25592968
   PubMed Web of Science ®Google Scholar
• Chen Y , Huang W , Sun W , et al. LncRNA MALAT1 promotes cancer metastasis in osteosarcoma via activation of the PI3K-akt signaling pathway. Cell Physiol Biochem . 2018;51(3):1313–1326. doi:10.1159/000495550 30481748
   PubMedGoogle Scholar
• Wang N , Hou MS , Zhan Y , Shen XB , Xue HY . MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway. Eur Rev Med Pharmacol Sci . 2018;22(22):7653–7659. doi:10.26355/eurrev_201811_16382 30536307
   PubMed Web of Science ®Google Scholar
• Yuan P , Cao W , Zang Q , Li G , Guo X , Fan J . The HIF-2alpha-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy. Biochem Biophys Res Commun . 2016;478(3):1067–1073. doi:10.1016/j.bbrc.2016.08.065 27524242
   PubMed Web of Science ®Google Scholar
• Li LJ , Chai Y , Guo XJ , Chu SL , Zhang LS . The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. Biomed Pharmacother . 2017;89:939–948. doi:10.1016/j.biopha.2017.02.011 28292022
   PubMed Web of Science ®Google Scholar
• Li P , Zhang X , Wang H , et al. MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2. Mol Cancer Ther . 2017;16(4):739–751. doi:10.1158/1535-7163.MCT-16-0591 28069878
   PubMed Web of Science ®Google Scholar
• Luo W , He H , Xiao W , et al. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A. Oncotarget . 2016;7(34):54733–54743. doi:10.18632/oncotarget.10752 27458156
   PubMedGoogle Scholar
• Cao Y , Zhang F , Wang H , et al. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis. Mol Cell Biochem . 2021;476(1):279–292. doi:10.1007/s11010-020-03904-6 32965597
   PubMed Web of Science ®Google Scholar
• Li Z , Wang Y , Hu R , Xu R , Xu W . LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity. Cell Prolif . 2018;51(6):e12504. doi:10.1111/cpr.12504 30182452
   PubMed Web of Science ®Google Scholar
• Fang Q , Chen X , Zhi X . Long non-coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b. Med Sci Monit . 2016;22:3506–3513. doi:10.12659/MSM.900688 27694794
   PubMed Web of Science ®Google Scholar
• Takahashi K , Yan IK , Wood J , Haga H , Patel T . Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res . 2014;12(10):1377–1387. doi:10.1158/1541-7786.MCR-13-0636 24874432
   PubMed Web of Science ®Google Scholar
• Zhang H , Guo Y , Song Y , Shang C . Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma. Cancer Chemother Pharmacol . 2017;79(1):49–55. doi:10.1007/s00280-016-3194-4 27878359
   PubMed Web of Science ®Google Scholar
• Shang C , Guo Y , Zhang H , Xue YX . Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma. Cancer Chemother Pharmacol . 2016;77(3):507–513. doi:10.1007/s00280-016-2964-3 26781446
   PubMed Web of Science ®Google Scholar
• Jiang M , Huang O , Xie Z , et al. A novel long non-coding RNA-ARA: adriamycin resistance-associated. Biochem Pharmacol . 2014;87(2):254–283. doi:10.1016/j.bcp.2013.10.020 24184505
   PubMed Web of Science ®Google Scholar
• Ma L , Xu Y , Xu X . Targeted MEK inhibition by cobimetinib enhances doxorubicin’s efficacy in osteosarcoma models. Biochem Biophys Res Commun . 2020;529(3):622–628. doi:10.1016/j.bbrc.2020.06.082 32736683
   PubMed Web of Science ®Google Scholar
• Noh K , Kim KO , Patel NR , et al. Targeting inflammatory kinase as an adjuvant treatment for osteosarcomas. J Bone Joint Surg Am . 2011;93(8):723–732. doi:10.2106/JBJS.J.00302 21508279
   PubMed Web of Science ®Google Scholar
• Zheng L , Fang S , Hui J , et al. Triptonide modulates MAPK signaling pathways and exerts anticancer effects via ER stress-mediated apoptosis induction in human osteosarcoma cells. Cancer Manag Res . 2020;12:5919–5929. doi:10.2147/CMAR.S258203 32765093
   PubMed Web of Science ®Google Scholar
• Xie SJ , Diao LT , Cai N , et al. mascRNA and its parent lncRNA MALAT1 promote proliferation and metastasis of hepatocellular carcinoma cells by activating ERK/MAPK signaling pathway. Cell Death Discov . 2021;7(1):110. doi:10.1038/s41420-021-00497-x 34001866
   PubMed Web of Science ®Google Scholar
• Fan YZ , Huang H , Wang S , Tan GJ , Zhang QZ . Effect of lncRNA MALAT1 on rats with myocardial infarction through regulating ERK/MAPK signaling pathway. Eur Rev Med Pharmacol Sci . 2019;23(20):9041–9049. doi:10.26355/eurrev_201910_19306 31696494
   PubMed Web of Science ®Google Scholar
• Shi YL , Wang Q , Wei JC . Influence of lncRNA-MALAT1 on neuronal apoptosis in rats with cerebral infarction through regulating the ERK/MAPK signaling pathway. Eur Rev Med Pharmacol Sci . 2019;23(18):8039–8048. doi:10.26355/eurrev_201909_19020 31599429
   PubMed Web of Science ®Google Scholar
• Huo Y , Li Q , Wang X , et al. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2. Oncotarget . 2017;8(29):46993–47006. doi:10.18632/oncotarget.16551 28388584
   PubMedGoogle Scholar